Mark J. Harding

1.3k total citations
37 papers, 1.0k citations indexed

About

Mark J. Harding is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Mark J. Harding has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Mark J. Harding's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Cannabis and Cannabinoid Research (9 papers) and Substance Abuse Treatment and Outcomes (8 papers). Mark J. Harding is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Cannabis and Cannabinoid Research (9 papers) and Substance Abuse Treatment and Outcomes (8 papers). Mark J. Harding collaborates with scholars based in United States, Tanzania and Australia. Mark J. Harding's co-authors include Graeme Mardon, David A. Nielsen, Thomas R. Kosten, Yi Zhou, Patrik Verstreken, Hugo J. Bellen, Tuan Pham, Brooke W. Middlebrooks, Sara Hamon and Thomas W. Molitor and has published in prestigious journals such as Development, Biological Psychiatry and Journal of Clinical Microbiology.

In The Last Decade

Mark J. Harding

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Harding United States 16 372 357 287 258 147 37 1.0k
R. W. Storts United States 19 269 0.7× 195 0.5× 132 0.5× 89 0.3× 76 0.5× 54 1.0k
I. Seif France 15 496 1.3× 365 1.0× 221 0.8× 51 0.2× 177 1.2× 26 1.2k
Curtis A. Machida United States 23 1.3k 3.4× 901 2.5× 180 0.6× 95 0.4× 277 1.9× 59 2.2k
Jingjing Liang China 20 556 1.5× 78 0.2× 145 0.5× 298 1.2× 140 1.0× 73 1.4k
Amanda Hanna United Kingdom 17 329 0.9× 330 0.9× 526 1.8× 74 0.3× 73 0.5× 21 1.4k
Ryoko Ishihara Japan 19 144 0.4× 122 0.3× 118 0.4× 86 0.3× 113 0.8× 55 905
A. Taylor Bright United States 15 443 1.2× 84 0.2× 209 0.7× 95 0.4× 203 1.4× 20 1.8k
Claudia T. Flynn United States 21 375 1.0× 108 0.3× 575 2.0× 66 0.3× 60 0.4× 40 1.5k
Geetha Kannan United States 23 368 1.0× 184 0.5× 404 1.4× 57 0.2× 110 0.7× 33 1.4k
Elsa Suberbielle France 11 474 1.3× 160 0.4× 160 0.6× 51 0.2× 104 0.7× 16 996

Countries citing papers authored by Mark J. Harding

Since Specialization
Citations

This map shows the geographic impact of Mark J. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Harding more than expected).

Fields of papers citing papers by Mark J. Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Harding. The network helps show where Mark J. Harding may publish in the future.

Co-authorship network of co-authors of Mark J. Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Harding. A scholar is included among the top collaborators of Mark J. Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Harding. Mark J. Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graham, David P., Mark J. Harding, & David A. Nielsen. (2022). Pharmacogenetics of Addiction Therapy. Methods in molecular biology. 2547. 437–490. 3 indexed citations
2.
Graham, David P., et al.. (2021). Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine. Behavioural Brain Research. 418. 113675–113675. 2 indexed citations
3.
Spellicy, Catherine J., et al.. (2019). Pharmacogenetic Role of Dopamine Transporter (SLC6A3) Variation on Response to Disulfiram Treatment for Cocaine Addiction. American Journal on Addictions. 28(4). 311–317. 16 indexed citations
4.
Nielsen, David A., Huiqiong Deng, Michelle A. Patriquin, et al.. (2019). Association of TPH1 and serotonin transporter genotypes with treatment response for suicidal ideation: a preliminary study. European Archives of Psychiatry and Clinical Neuroscience. 270(5). 633–642. 12 indexed citations
5.
Nielsen, David A., Catherine J. Spellicy, Mark J. Harding, & David P. Graham. (2018). Apolipoprotein E DNA methylation and posttraumatic stress disorder are associated with plasma ApoE level: A preliminary study. Behavioural Brain Research. 356. 415–422. 10 indexed citations
6.
Curtis, Kaylah N., Humsini Viswanath, Kenia M. Velasquez, et al.. (2017). Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant. American Journal on Addictions. 26(7). 751–759. 27 indexed citations
7.
Patriquin, Michelle A., Sara Hamon, Mark J. Harding, et al.. (2017). Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes. Psychiatric Genetics. 27(5). 178–186. 5 indexed citations
8.
Shorter, Daryl, et al.. (2013). Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variation. European Neuropsychopharmacology. 23(11). 1401–1407. 22 indexed citations
9.
Spellicy, Catherine J., Thomas R. Kosten, Sara Hamon, Mark J. Harding, & David A. Nielsen. (2013). The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency. Frontiers in Psychiatry. 3. 109–109. 12 indexed citations
10.
Graham, David P., Drew A. Helmer, Mark J. Harding, et al.. (2013). Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans. Journal of Psychiatric Research. 47(6). 835–842. 41 indexed citations
11.
Nielsen, David A., et al.. (2012). Modifying the role of serotonergic5‐HTTLPRandTPH2variants on disulfiram treatment of cocaine addiction: a preliminary study. Genes Brain & Behavior. 11(8). 1001–1008. 27 indexed citations
12.
Kosten, Thomas R., et al.. (2012). Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase. Biological Psychiatry. 73(3). 219–224. 78 indexed citations
13.
Vareki, Saman Maleki, Mark J. Harding, Jason Waithman, et al.. (2011). Differential Regulation of Simultaneous Antitumor and Alloreactive CD8+ T-Cell Responses in the Same Host by Rapamycin. American Journal of Transplantation. 12(1). 233–239. 6 indexed citations
14.
Davis, Richard J., Mark J. Harding, Yalda Moayedi, & Graeme Mardon. (2008). Mouse Dach1 and Dach2 are redundantly required for Müllerian duct development. genesis. 46(4). 205–213. 31 indexed citations
15.
Davis, Richard J., et al.. (2006). MouseDach2 mutants do not exhibit gross defects in eye development or brain function. genesis. 44(2). 84–92. 30 indexed citations
16.
Harding, Mark J., et al.. (1997). Specificity and nucleotyping studies of a gp50-based polymerase chain reaction assay for detection of pseudorabies virus.. PubMed. 61(2). 157–60. 3 indexed citations
17.
Gradil, Carlos M., Mark J. Harding, & Keir Lewis. (1994). Use of polymerase chain reaction to detect porcine parvovirus associated with swine embryos. American Journal of Veterinary Research. 55(3). 344–347. 15 indexed citations
18.
Harding, Mark J. & Thomas W. Molitor. (1992). A monoclonal antibody which recognizes cell surface antigen and inhibits porcine parvovirus replication. Archives of Virology. 123(3-4). 323–333. 3 indexed citations
19.
Hayward, Neil J., Mark J. Harding, S A Lloyd, et al.. (1991). The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. British Journal of Pharmacology. 104(4). 973–977. 34 indexed citations
20.
Harding, Mark J. & Thomas W. Molitor. (1988). Porcine parvovirus: replication in and inhibition of selected cellular functions of swine alveolar macrophages and peripheral blood lymphocytes. Archives of Virology. 101(1-2). 105–117. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. W. Storts Breakdown of academic impact, for papers by I. Seif Breakdown of academic impact, for papers by Curtis A. Machida Breakdown of academic impact, for papers by Jingjing Liang Breakdown of academic impact, for papers by Amanda Hanna Breakdown of academic impact, for papers by Ryoko Ishihara Breakdown of academic impact, for papers by A. Taylor Bright Breakdown of academic impact, for papers by Claudia T. Flynn Breakdown of academic impact, for papers by Geetha Kannan Breakdown of academic impact, for papers by Elsa Suberbielle
Rankless by CCL
2026